ClinicalTrials.gg
Status unknownNCT04922983Updated Oct 19, 2023

Incobotulinumtoxin A and Yoga-like Isometric Exercise in Adolescent Idiopathic Lumbar Scoliosis

A Phase 2 interventional study of Botulinum toxin type A and Isometric Yoga-like exercise in Scoliosis Idiopathic, Scoliosis; Adolescence and Scoliosis; Lumbar Region, sponsored by Manhattan Physical Medicine and Rehabilitation, LLP. Status unknown at 1 site in United States. Open to participants aged 14 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-19.

Sponsored by Manhattan Physical Medicine and Rehabilitation, LLP · Phase 2, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2023), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 2
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
14 Years to 18 Years
Sex
All
01

Study summary

The study uses a yoga-like isometric posture and botulinum injections to reduce the curves in adolescent idiopathic lumbar scoliosis. Three previous studies show that the yoga pose is effective for reversing scoliotic curves; Botulinum toxin has been approved by the FDA for teenagers. However, no studies using the two of them together have been done until this one.

Read the detailed description

The randomized control 6-month study employs an isometric yoga-like posture to strengthen the weak side, and one set of botulinum injections to weaken the strong side of adolescent idiopathic lumbar scoliosis between 25 and 60 degrees. It is open to people between 12 and 18 years of age who are willing to do the pose every day for three months.

This is a crossover study: After 3 months, every patient who was placebo will be offered the actual proven yoga pose and botulinum toxin injections. Two additional free X-rays at 3 weeks and 3 months following the botulinum injection will also be available to each placebo patient.

In this way every patient - placebo or not - will receive the full proper treatment within 3 months.

02

Conditions studied

  • Scoliosis Idiopathic
  • Scoliosis; Adolescence
  • Scoliosis; Lumbar Region

Browse trials for

Keywords

  • Adolescent idiopathic scoliosis
  • scoliosis
  • yoga
  • isometric
  • botulinum
03

In context

Scoliosis

603 studies on the registry are indexed under Scoliosis; 141 are open to participants now.

This study's planned enrollment of 42 is close to the median of 44 across 350 interventional studies indexed under Scoliosis.

Browse Scoliosis studies →

Lead sponsor

Manhattan Physical Medicine and Rehabilitation, LLP is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

1. Fourteen - 18 years of age, 2. Scoliotic curve greater than 25 degrees, less than 45 degrees, 3. Stated willingness to do the yoga and yoga-like poses daily, 4. Written, signed consent by patient and parent/guardian 5. Pre-test Cobb films no less than 3 months old read by independent radiologists.

Exclusion criteria

  • Exclusion Criteria:

    1. Neurological, muscular or neuromuscular disease, (e.gs., cerebral palsy, myopathy, stroke),
    2. Genetic abnormalities that affect limb growth, proportionality or metabolism, (e.gs., mucopolysaccharidoses, Marfan's syndrome, Refsums disease).
    3. Pregnancy and other conditions prohibiting X-rays or minute(s)-long exertion (e.gs., congestive heart failure, great weakness, COPD).
    4. Previous exposure to botulinum neurotoxin Type A. Sexually active female subjects must present a recent negative pregnancy test.
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
42 participants (estimated)

Study arms

  • Sham comparator
    Group I: Placebo isometric measure, no injection

    Group I: no isometric yoga-like exercise, no injection given.

    Behavioral: Placebo

  • Placebo comparator
    Group II Isometric yoga-like exercise, placebo injection given

    Group II isometric yoga-like exercise, injection of preservative-free normal saline.

    Behavioral: Isometric Yoga-like exercise

  • Active comparator
    Group III: True isometric exercise, botulinum injection

    Group III: Isometric yoga-like exercise, botulinum injection given

    Drug: Botulinum toxin type A · Behavioral: Isometric Yoga-like exercise

  • Active comparator
    Crossover

    After the three months, Arm I and Arm II patients will be given botulinum injections, and Group I will be given the proper yoga-like exercise. These two arms will constitute a further comparator with their own performances in the first 3 months of the study.

    Drug: Botulinum toxin type A · Behavioral: Isometric Yoga-like exercise

Interventions

  • A position similar to the side-plank (Vasisthasana) held for maximal time at least once daily (usual duration: 30 - 90 seconds).

    Also known as: Incobotulinumtoxin A

  • BehavioralIsometric Yoga-like exercise

    Extended torso and legs held diagonally by one straight arm, back against wall if necessary

    Also known as: Side-Plank, Vasisthasana

  • BehavioralPlacebo

    Used as placebo

    Also known as: no active intervention by drug or yoga-like exercise

06

What researchers measure

Primary outcomes

  1. Reduction in lumbar and thoracic scoliotic curve

    Measured by the Cobb angle in coronal X-rays

    Time frame: At study onset

  2. Reduction in lumbar and thoracic scoliotic curve

    Measured by the Cobb angle in coronal X-rays

    Time frame: 3 weeks after study onset

  3. Reduction in lumbar and thoracic scoliotic curve

    Measured by the Cobb angle in coronal X-rays

    Time frame: 3 months after study onset

  4. Reduction in lumbar and thoracic scoliotic curve

    Measured by the Cobb angle in coronal X-rays

    Time frame: 3 weeks after crossover group injections

  5. Reduction in lumbar and thoracic scoliotic curve

    Measured by the Cobb angle in coronal X-rays

    Time frame: 3 months after crossover group injections

07

Study locations

1 of 1 sites recruiting
  • Manhattan Physical Medicine and Rehabilitation, PLLC
    Manhattan, New York 10022, United States
    Recruiting
08

References and documents

Publications

  • Fishman LM, Groessl EJ, Sherman KJ. Serial case reporting yoga for idiopathic and degenerative scoliosis. Glob Adv Health Med. 2014 Sep;3(5):16-21. doi: 10.7453/gahmj.2013.064. PubMed 25568820 ↗
  • Fishman LM. Isometric Yoga-Like Maneuvers Improve Adolescent Idiopathic Scoliosis-A Nonrandomized Control Trial. Glob Adv Health Med. 2021 Feb 24;10:2164956120988259. doi: 10.1177/2164956120988259. eCollection 2021. PubMed 33717658 ↗
  • Fishman LM, Groessl EJ, Bernstein P.Two Isometric Yoga Poses Reduce the Curves in Degenerative and Adolescent Idiopathic Scoliosis. Topics in Geriatric Rehabilitation. 33(4):231-237, October/December, 2017.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 19, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04922983
Lead sponsor
Manhattan Physical Medicine and Rehabilitation, LLP
Responsible party
Sponsor
First posted
Jun 11, 2021
Start date
Jul 1, 2021
Primary completion
Jul 1, 2025 (estimated)
Completion
Jan 1, 2026 (estimated)
Last update
Oct 19, 2023

Study contacts

Loren M Fishman, MD
Contact
lorenmartinfishman@gmail.com
646-642-0700
Cara M Cipriano, BA
Contact
Cara@sciatica.org
(2120 472-0077
Loren M Fishman
principal investigator · Columbia University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Botulinum toxin type A

Start the discussion